Thomas v. Takeda Pharmaceuticals USA, Inc. et al

Filing 32

ORDER Granting 27 Motion for a Stay Pending the Judicial Panel on Multidistrict Litigation's Resolution of the Motion to Transfer signed by Chief Judge Lawrence J. O'Neill on 07/25/2017. (Flores, E)

1
2
3
UNITED STATES DISTRICT COURT
4
FOR THE EASTERN DISTRICT OF CALIFORNIA
5
6

SHARRON THOMAS,

7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24

1:16-cv-1566-LJO-EPG

Plaintiff,

ORDER GRANTING MOTION FOR A
STAY PENDING THE JUDICIAL
PANEL ON MULTIDISTRICT
LITIGATION’S RESOLUTION OF THE
MOTION TO TRANSFER PURSUANT
TO 28 U.S.C. § 1407

v.
TAKEDA PHARMACEUTICALS
USA, INC., TAKEDA
PHARMACEUTICALS AMERICA,
INC.; TAKEDA
PHARMACEUTICALS
INTERNATIONAL INC.; TAKEDA
DEVELOPMENT CENTER
AMERICAS, INC.; TAKEDA GMBH;
TAKEDA PHARMACEUTICAL
COMPANY LIMITED,
Defendants.

The Motion For A Stay Pending The Judicial Panel On Multidistrict Litigation’s Resolution Of
The Motion To Transfer Pursuant To 28 U.S.C. § 1407 submitted by Plaintiff Sharron Thomas
(“Plaintiff”) on June 28, 2017, the Court, having received all evidence and the matter having been
submitted, ORDERS as follows:
IT IS HEREBY ORDERED that:
1. All proceedings in this action are stayed pending the decision of the Judicial Panel on
Multidistrict Litigation (“JPML”) On the Motion for Transfer filed on June 2, 2017 to transfer this
action and one hundred sixty-five others to a multidistrict litigation, which be established in the United
States District Court Of New Jersey. See Ex. 1, Memorandum in Support of Plaintiffs’ Motion for

25
1

1

Transfer of Actions to the United States District Court for the District of New Jersey Pursuant to 28

2

U.S.C. § 1407 and JPML Rule 7.2 for Coordinated Pretrial Proceedings; and Ex. 2, In re: Proton-Pump

3

Inhibitor Product Liability Litigation (MDL No. 2789), Schedule of Actions.

4

2. The Scheduling Conference set for July 24, 2017, along with corresponding deadlines for the

5

parties to meet and confer and submit a Joint Scheduling Report in advance of the Scheduling

6

Conference, is adjourned, including a stay of all corresponding deadlines for the parties to hold a

7

discovery conference and submit a Joint Scheduling Report, until after the JPML decides the motion

8

requesting an MDL.

9
10 IT IS SO ORDERED.
11

Dated:

/s/ Lawrence J. O’Neill _____

July 25, 2017

UNITED STATES CHIEF DISTRICT JUDGE
12
13
14
15
16
17
18
19
20
21
22
23
24
25
2